Adenovirus vectors activate Vd2+ ?dT cells in a type I interferon-, TNF-, and IL-18-dependent manner. (2022)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/eji.202149367
PubMed Identifier: 34958459
Publication URI: http://europepmc.org/abstract/MED/34958459
Type: Journal Article/Review
Volume: 52
Parent Publication: European journal of immunology
Issue: 5
ISSN: 0014-2980